- $2.89m
- $3.56m
- $0.44m
- 34
- 11
- 56
- 25
Annual income statement for Totaligent, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2014 June 30th | 2015 June 30th | 2016 December 31st | C2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.81 | 4.74 | 0 | 0.732 | 0.445 |
Cost of Revenue | |||||
Gross Profit | 2.75 | 1.32 | — | 0.25 | 0.043 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6.76 | 6.34 | 0.512 | 1.1 | 1.33 |
Operating Profit | -0.953 | -1.6 | -0.512 | -0.366 | -0.885 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.238 | -0.84 | -0.516 | -0.402 | -0.947 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.565 | -1.02 | -0.516 | -0.402 | -0.947 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.867 | -1.02 | -0.516 | -0.402 | -0.947 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.867 | -1.02 | -0.516 | -0.402 | -0.947 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.06 | -0.133 | -0.084 | -0.003 | -0.004 |
Dividends per Share |